Hermes Vector

Health

FDA Reports Link Energy Drinks and Stimulants to Increased Cardiac Arrest Risk

Preliminary research presented at the American Heart Association's Scientific Sessions 2026 links caffeinated energy drinks and stimulant supplements to higher rates of cardiac arrest and heart attacks in young adults.

By Hermes-Vector AI Desk

Checked against 6 sourcesnewsroom.heart.orgnutritioninsight.commedicaldaily.comphillyvoice.comwgauradio.comsouthfloridareporter.com
Illustration for: FDA Reports Link Energy Drinks and Stimulants to Increased Cardiac Arrest Risk

In brief

  • FDA reports show cardiac arrest is 11 times more frequent in connection with caffeine and stimulant products than non-stimulant products.
  • Approximately 45% of reported cardiovascular events involving these products occurred in adults aged 18 to 34.
  • The study analyzed 28,345 voluntary adverse-event reports submitted to the FDA between 2017 and 2025.
  • Researchers noted that the study shows an association but does not prove that these products directly cause heart events.

FDA Reports Link Energy Drinks and Stimulants to Increased Cardiac Arrest Risk

Preliminary research to be presented at the American Heart Association’s Scientific Sessions 2026 indicates that caffeinated energy drinks and stimulant supplements are disproportionately represented in FDA reports of serious cardiovascular events. The study, which analyzed 28,345 adverse-event reports to the FDA from 2017 to 2025, found that cardiac arrest was reported approximately 11 times more often in connection with caffeine- and stimulant-containing products compared to products without these ingredients.

Study Findings and Demographics

The analysis, conducted by researchers from the University of Virginia School of Medicine, focused on reports from individuals aged 13 or older. Key findings from the 854 reports involving caffeine or stimulants include:

  • Cardiac Arrest: Reported about 11 times more often than in reports for products without stimulants.
  • Heart Attacks: Reports were approximately 4.5 times more likely to include heart attacks.
  • Arrhythmias: Reports were four times more likely to include ventricular arrhythmias or heart palpitations.
  • Other Symptoms: The study noted higher reporting of elevated heart rate (nearly 3 times more often), chest pain (2.71 times more often), and fainting (about 2 times more often).

Approximately 45% of the reports linking these products to cardiovascular events involved adults between the ages of 18 and 34, a demographic not typically considered at high risk for such events.

Product Regulation and Caffeine Content

Because the U.S. Food and Drug Administration (FDA) regulates energy drinks and stimulant supplements as foods or dietary supplements rather than medications, these products do not undergo the same premarket safety testing required for medications.

According to a 2026 American Heart Association Scientific Statement, consuming up to 400 mg of caffeine per day is generally safe for most adults. However, the study noted significant variations in caffeine concentration across products:

Product TypeCaffeine Concentration Comparison
Energy DrinksUp to 3 times more caffeine per fluid ounce than brewed coffee
Pre-workout SupplementsMore than 12 times as much caffeine per fluid ounce as brewed coffee

Limitations and Expert Perspectives

The study authors emphasized that the analysis design only identified associations between caffeinated products and cardiac events voluntarily self-reported to the FDA; the results cannot prove that these products directly caused these heart conditions.

"Although there are biological reasons why that connection could be possible, the study does not prove that caffeine products cause these events, because other factors may have influenced the results found in this analysis," said Gregory M. Marcus, M.D., M.A.S., FAHA, who chaired the American Heart Association's 2026 scientific statement on caffeine and cardiovascular disease.

Sai Samayamanthula, the study's lead author and a fourth-year medical student at the University of Virginia School of Medicine, noted that while the risk may be small for occasional users, regular consumption can lead individuals to quickly exceed recommended daily limits. "Our findings support the case for more systematic safety monitoring of caffeine- and stimulant-containing products," Samayamanthula said.

Why it matters

As sales of caffeinated energy drinks have more than doubled over the past decade, reaching over $20 billion in 2024, researchers are investigating the potential cardiovascular impacts of high-dose stimulant consumption. The researchers noted that the high frequency of reports among young adults may be due to consumption patterns, such as mixing stimulants with alcohol or drugs, or the presence of undiagnosed heart conditions.


Sources

This article was drafted with AI assistance and checked against the sources above. Company claims are reported as claims. Cover image is AI-generated.

The day's checked news, by email

One short email a day with the top stories. Free, and you can unsubscribe in one click.

Or follow for the latest news:

Advertisement

How do you feel about this story?

Comments 0

No comments yet. Start the discussion.